About this trial
A study to evaluate the use of density spectral array display in comparison with Bispectral index in a clinical setting.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥ 65 years undergoing elective procedures of 1-3 hours' duration requiring GA.
Procedures in which a DoA monitor can be applied to the forehead.
Patients receiving intravenous propofol and opiate anaesthesia using supraglottic airway device.
Patient able to provide informed consent.
Disqualifiers
Administration of ketamine/dexmedetomidine.
Administration of inhaled anaesthetic agents or nitrous oxide
Administration of muscle relaxation
Trial population
• Age ≥ 65 years undergoing elective procedures of 1-3 hours' duration requiring GA at RBWH
Trial design
Cohort
Prospective
Treatments tested in this trial
Depth of anesthesia monitoring using processed EEG
DeviceComparison of processed EEG monitor (Bispectral index) with and without Density spectral array
Treatment groups
Trial outcomes
Primary outcomes
aim
Sensitivity and specificity of Bispectral index combined with density spectral array compared with Bispectral index alone in detection of emergence from general anesthesia. Emergence from anaesthesia manifests in changes in the BIS and/or DSA suggestive of a change in the depth of anesthesia and progress towards regaining consciousness.
Primary aim
Evaluate the sensitivity and specificity of Bispectral index combined with density spectral array compared with Bispectral index alone in the detection of the timing of emergence from general anesthesia.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
The University of Queensland
Lead sponsor
Medtronic
Collaborator
This trial is not recruiting at the moment. You can still explore other options: